Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine

Journal of Neuroimmunology

Volumn 250, Issue 1-2, 2012, Pages 94-98

  Poulas, Konstantinos ^a,b   Koutsouraki, Euphrosyni ^c   Kordas, Gregory ^a   Kokla, Anna ^b   Tzartos, Socrates J ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Acetylcholine receptor; Autoantibodies; D penicillamine; MuSK; Myasthenia gravis

Indexed keywords

CORTISONE; HYDROXYCHLOROQUINE; MUSCLE SPECIFIC KINASE; NICOTINIC ACETYLCHOLINE RECEPTOR ANTIBODY; NICOTINIC RECEPTOR; PENICILLAMINE; PHOSPHOTRANSFERASE; PREDNISONE; PROTEIN ANTIBODY; PYRIDOSTIGMINE; TUMOR MARKER; UNCLASSIFIED DRUG;

AGED; ANTIBODY TITER; ARTHRITIS; ARTICLE; BLOOD EXAMINATION; BRAIN CORTEX ATROPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE COURSE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROENCEPHALOGRAM; ENDOSCOPY; ESOPHAGUS MOTILITY; FATIGUE; FEMALE; GLAUCOMA; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; LABORATORY TEST; LEG PAIN; MYASTHENIA GRAVIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PTOSIS; RAYNAUD PHENOMENON; SCLERODERMA; SKIN DEFECT; STOMACH MOTILITY; STOMACH ULCER; SYMPATHECTOMY; THYMUS; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTIRHEUMATIC AGENTS; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; MYASTHENIA GRAVIS; PENICILLAMINE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; SCLERODERMA, SYSTEMIC;

EID: 84864853010     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.05.011     Document Type: Article

References (26)

1. Atcheson S.G., Ward J.R. Ptosis and weakness after start of d-penicillamine therapy. Ann. Intern. Med. 1978, 89:939-940.
2. Barrons R.W. Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy 1997, 17(6):1220-1232.
3. Bucknall R.C., Dixon A.J., Glick E.N., Woodland J., Zutshi D.W. Myasthenia gravis associated with penicillamine treatment of rheumatoid arthritis. Br. Med. J. 1975, 1:600-602.
4. Conti-Fine B.M., Diethelm-Okita B., Ostlie N., Wang W., Milani M. Immunopathogenesis of myasthenia gravis. Myasthenia Gravis and Related Disorders 2003, 53-92. Humana Press Inc, N. Jersey, USA. H.J. Kaminski (Ed.).
5. D'Anglejan J., Morel E., Feuillet-Fieux M.N., Raimond F., Vernet der Garabedian B., Jacob L., et al. Myasthenia induced by d-penicillamine. Study of immuno-clinical correlations in 23 cases. Presse Med. 1985, 14(46):2336-2340.
6. Dawkins R.L., Zilko P.J. Penicillamine: friend or foe?. Aust. N. Z. J. Med. 1979, 9:494-495.
7. Epstein O., DeVilliers D., Jains S., Potter B.J., Thomas H.C., Sherlock S. Reduction of immune complexes and immunoglobins induced by d-penicillamine in primary biliary cirrhosis. N. Engl. J. Med. 1979, 300:274-278.
8. Fridkis-Hareli M. Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases. J. Autoimmune Dis. 2008, 5:1.
9. Gordon R.A., Burnside J.W. d-penicillamine induced myasthenia gravis in rheumatoid arthritis. Ann. Intern. Med. 1977, 87:78-79.
10. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., Vincent A. Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 2001, 7:365-368.
11. Jaffe I.A. Rheumatoid arthritis with arteritis: report of a case treated with d-penicillamine. Ann. Intern. Med. 1964, 61:556-563.
12. Jaffe I.A. Penicillamine treatment of rheumatoid arthritis. Rationale, pattern of clinical response and clinical pharmacology and toxicology. Penicillamine Research in Rheumatoid Disease 1976, 11-24. Fabritius and Sonner, Oslo, Norway. E. Munthe (Ed.).
13. Jha S., Xu K., Maruta T., Oshima M., Mosier D.R., Atassi M.Z., et al. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J. Neuroimmunol. 2006, 175:107-117.
14. Katz L.J., Lesser R.L., Merikangas J.R., Silverman J.P. Ocular myasthenia gravis after d-penicillamine administration. Br. J. Ophthalmol. 1989, 73:1015-1018.
15. Lindstrom J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 1981, 74:432-460.
16. Main R.N., Roffe L. d-penicillamine and lymphocyte function in rheumatoid arthritis: the inhibitory and augmenting effects of d-penicillamine in vitro on phytohemagglutinin-induced lymphocyte transformation. Penicillamine Research in Rheumatoid Disease 1976, 172-184. Fabritius and Sonner, Oslo, Norway. E. Munthe (Ed.).
17. Masters C.L., Dawkins R.I., Zilko P.J., Simpson J.A., Leedman R.J. Penicillamine associated myasthenia gravis antiacetylcholine receptor and antistriational antibodies. Am. J. Med. 1977, 63:689-694.
18. McConville J., Farrugia M.E., Beeson D., Kishore U., Metcalfe R., Newsom-Davis J., et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann. Neurol. 2004, 55:580-584.
19. Meriggioli M.N., Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009, 8(5):475-490.
20. Padua L., Tonali P., Aprile I., Caliandro P., Bartoccioni E., Evoli A. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients. Eur. J. Neurol. 2006, 13:273-276.
21. Shigemoto K., Kubo S., Jie C., Hato N., Abe Y., Ueda N., et al. Myasthenia gravis experimentally induced with muscle-specific kinase. Ann. N. Y. Acad. Sci. 2008, 1132:93-98.
22. Suhail H., Vivekanandhan S., Singh S., Behari M. Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient. Neurol. India 2010, 58(4):668-669.
23. Trakas N., Zisimnopoulou P., Tzartos S.J. Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis. J. Neuroimmunol. 2011, 240-241:79-86.
24. Tsiamalos P., Kordas G., Kokla A., Poulas K., Tzartos S.J. Epidemiological and immunological profile of MuSK myasthenia gravis in Greece. Eur. J. Neurol. 2009, 16:925-930.
25. Tzartos S.J., Morel E., Efthimiadis A., Bustarret A.F., D'Anglejan J., Drossos A.A., et al. Fine antigenic specificities of antibodies in sera from patiens with d-Penicillamine-induced myasthenia gravis. Clin. Exp. Immunol. 1988, 74:80-86.
26. Vincent A., Palace J., Hilton-Jones D. Myasthenia gravis. Lancet 2001, 357:2122-2128.